NY Times on Arthritis Prevention

Save

A reader question ("Ask Well") to the New York times wonders "is arthritis avoidable"?

A recent survey suggests that up to 60% of adults have been told by an HCP they had some form of arthritis.

Want to Go Far, Go Together (4.21.2023)

Save

This week on the podcast Dr. Jack Cush reviews the news, regulatory announcements and novel journal reports including a profile on pseudogout, the safety of immune checkpoint inhibitors in RA patients and the diagnostic importance of neutrophils.

Aging Mechanisms Tied to Giant Cell Arteritis

Save

Senescence pathways are involved in giant cell arteritis (GCA), an analysis of patient tissue samples suggested, which may account for the efficacy of one agent now used for the disease and another in commercial development.

The Power of Collaboration: Building Relationships to Amplify Your Impact and Have More Fun

Save

Collaboration has proven to be an essential ingredient for progress and innovation in rheumatology. Effective collaboration requires generosity with your time and resources. Here are some things that I’ve learned over the years about successful collaborations in rheumatology.

Sex-Specific Differences in Psoriatic Arthritis

Save

A systematic review of published literature on psoriatic arthritis (PsA), clinical features, disease activity, and patient-reported outcomes (PROs) shows generally higher levels of disease activity in women, compared to men with PsA.

Amgen Wins Otezla Patent Case - Brand Protected till 2028

Save

Amgen Inc convinced a U.S. appeals court on Wednesday to uphold patents that bar generic versions of its blockbuster psoriasis drug Otezla proposed by Zydus Pharmaceuticals and Novartis AG's Sandoz Inc until 2028.